Features

How patient experience data prompted patient engagement improvements

PatientEngagementHIT Ensuring an optimal patient experience might be a personal and professional passion for Shanna McCann, a senior experience coach at Children’s Minnesota Pediatric Hospital, but she knows making those improvements relies on cold, hard...

Understanding the environmental impact of the pharmaceutical industry

PharmaNewsIntelligence The pharmaceutical industry is crucial in improving global health by developing and manufacturing life-saving medications. However, it also has a significant environmental impact that cannot be ignored.   The Pharmaceutical...

Common remote patient monitoring tools

mHealthIntelligence Remote patient monitoring (RPM) is a valuable healthcare delivery mechanism. RPM allows healthcare providers to continuously track patient health metrics over time, giving them a comprehensive view of the patient’s condition and how...

How are Medicare plans lowering drug costs for beneficiaries?

HealthPayerIntelligence Affordable access to prescription drugs is a necessity for managing chronic and acute conditions and staying healthy. However, as drug costs rise, both affordability and accessibility are dwindling. Over 80 percent of surveyed adults said...

Exploring RNA-based therapeutics beyond mRNA vaccines

LifeSciencesIntelligence RNA therapeutics have emerged as a critical tool for the healthcare industry. In recent years, mRNA vaccines have been one of the most notable RNA therapeutics, which played a crucial role in curbing the effects of the COVID-19 pandemic....

Strategies for engaging, managing KOLs in the pharma industry

PharmaNewsIntelligence Key opinion leaders (KOLs) are healthcare providers (HCPs) and industry leaders who play a critical role in the healthcare industry, acting as vital stakeholders for the sector, including life sciences and pharmaceutical companies....

Assessing the impacts of noncontinuous digital diabetes solutions

LifeSciencesIntelligence In a recent health technology assessment conducted by the Peterson Health Technology Institute (PHTI), the clinical and economic impact of noncontinuous digital diabetes management solutions for adults with type 2 diabetes (T2D) has been...

Artificial intelligence in healthcare: defining the most common terms

HealthITAnalytics As healthcare organizations collect more and more digital health data, transforming that information to generate actionable insights has become crucial. Artificial intelligence (AI) has the potential to significantly bolster these efforts,...

Why Ochsner & Humana struck an RPM partnership for chronic care

mHealthIntelligence Remote patient monitoring (RPM) tools and services have proven remarkably effective at improving chronic disease management. However, access to RPM programs can be challenging, particularly for underserved populations. One strategy to break...

Applying pharmacometabolomic data for personalized medicine

LifeSciencesIntelligence As healthcare evolves and science advances, the industry has increasingly focused on personalized medicine as an alternative to blanket, one-size-fits-all treatments. This approach is an attempt to address ongoing concerns around treatment...

Addressing muscle loss associated with GLP-1 medication use

PharmaNewsIntelligence Glucagon-like peptide-1 (GLP-1) receptor agonists — also known as GLP-1 drugs — have gained a significant amount of attention in recent years because of their utility in managing type 2 diabetes (T2D) and, even more so, in...

Tailoring medication selection with pharmacogenomic testing

PharmaNewsIntelligence In modern healthcare, pharmacogenomic assessments are helping healthcare providers determine medication selection, ensuring tailored treatment plans for everyone’s unique genetic makeup. Pharmacogenomic Testing Drug–gene...

Protecting patient data sharing & ownership with ethical data use

PatientEngagementHIT In pursuit of consumer-centered healthcare, the medical industry has seen the growing prominence of patient data sharing. As consumerism has gripped the healthcare industry, health systems across the country are working to crack the code of...

Understanding litigation against drug, medical device manufactures

LifeSciencesIntelligence Legal challenges surrounding medical devices and pharmaceutical drugs have become increasingly prominent in the healthcare industry. In an episode of Healthcare Strategies, Janpaul Portal, Esq, Managing Director of pharmaceutical and...

Establishing a telehealth alliance to boost rural healthcare access

mHealthIntelligence Rural healthcare provider organizations have a formidable mandate: improve health outcomes of underserved populations with shoestring budgets and limited clinical resources. Though virtual care approaches have proven valuable in expanding...

A consumer-obsessed strategy is key to rebuilding primary care

PatientEngagementHIT While healthcare consumerism has reshaped the way patients engage and feel empowered in their care, for many health systems, it’s had the opposite effect, fragmenting patient care access and threatening the continuity of primary care...

FDA-approved insulin pumps used for insulin pump therapy

LifeSciencesIntelligence Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), has emerged as a significant advancement in diabetes technology over the last 50 years. Although commercial insulin pumps were introduced in the 1970s,...

How can payers be prepared to manage third-party security incidents?

HealthPayerIntelligence Security breaches and cyberattacks occur in the healthcare space at alarming rates, creating privacy concerns for all stakeholders involved. While provider organizations are the most common entities in healthcare that experience a security...

Comparing inflammatory bowel disease treatment options

PharmaNewsIntelligence Last month, AbbVie sponsored several presentations and posters at the European Crohn's and Colitis Organization’s (ECCO) annual congress. Among these abstracts was the SEQUENCE study, which compared risankizumab and ustekinumab...